Neuro-oncological superiority of supratotal resection in lower-grade gliomas
This study supports the feasibility of SpTR in LGGs, its benefit at first and second surgery regardless of molecular subtypes, and on OS, significantly reducing recurrence when SpTR > 120%; SpTR also associates with the best patients' functional outcome.
Authors
- Antonella Leonetti (ORCID: https://orcid.org/0000-0002-5500-4901)
- Guglielmo Puglisi (ORCID: https://orcid.org/0000-0002-7690-1679)
- Marco Rossi (ORCID: https://orcid.org/0000-0002-0196-2370)
- Alberto L. Gallotti (ORCID: https://orcid.org/0000-0001-9698-7919)
- Francesco Bruno (ORCID: https://orcid.org/0000-0001-8087-5293)
- Marco Conti Nibali (ORCID: https://orcid.org/0000-0003-2611-5685)
- Tommaso Sciortino (ORCID: https://orcid.org/0000-0001-6214-1253)
- Lorenzo Bello (ORCID: https://orcid.org/0000-0001-6797-7105)
- Riccardo Soffietti (ORCID: https://orcid.org/0000-0002-9204-7038)
- Roberta Rudà (ORCID: https://orcid.org/0000-0001-9134-1537)
- Gabriella Cerri (ORCID: https://orcid.org/0000-0002-7202-3792)
- Lorenzo Gay
Institutions
- University of Milan (IT)
- University of Turin (IT)
Publication Details
- Journal
- Neuro-Oncology
- Published
- 2024-12-07
- DOI
- https://doi.org/10.1093/neuonc/noae264
- Citations
- 3
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.31
Funders
- Università degli Studi di Milano
- Associazione Italiana per la Ricerca sul Cancro